Define Blood Safety. Discuss the components of Blood Safety under the NACP – IV.

Describe the roles and responsibilities of the state AIDS control societies (SACS) in the NACP.

Discuss the strategies for prevention of HIV infection in the general population.

Role of ASHA in HIV Care

Outline the strategic information management system (SIMS). Discuss its role in the NACP.

Discuss the basics of social marketing of condom under the NACP.

Describe the concept and roles of Link Art Centres (LAC).

Discuss the linkages of the National AIDS control programme with other National Programmes. Describe in detail the linkages with the RNTCP.

Define targeted interventions. Discuss the targeted intervention strategies under NACP – IV for intravenous drug users (IDUs).

Discuss briefly WHO clinical staging of HIV disease in adults and adolescents.

Describe the common clinical manifestations of HIV infections in an adult.

Discuss the diagnosis of HIV infections in children and infants below 18 months of age.

Describe the various methods for HIV– DR testing.

Describe CD4 T cells and viral load testing as used in the National Programme

Discuss the various strategies of HIV testing

A 24 yr old PLHIV presents with fever, weight loss (~ 20Kg) and painful deglutination. What WHO clinical stage of HIV infection is the patient in? Describe the differences between WHO clinical staging and CDC classification of HIV infection in adults.

. Describe the relationship of CD4 count and opportunistic infections in HIV. Stage HIV infected patients based on presentation of OIs (opportunistic infections).

Enumerate the different factors influencing disease progression in HIV infection.

Describe the current global scenario of HIV/AIDS.

Role of genetics in Drug Resistance.